If your pharmacy has recently been through an OptumRx® desk audit, you may have come across the OptumRx Provider Intent Form – Recoupment Waiver. This one-page form accompanies initial audit results and if signed, gives OptumRx® even greater power over the pharmacy. A signature on the form indicates the following:
There is no apparent benefit to the pharmacy by signing this form. Additionally, signing and agreeing to the preliminary audit findings could be construed as the pharmacy’s admission of wrongdoing. Only OptumRx® would benefit from this waiver and PAAS National® does not feel it is in the best interest of pharmacies to sign.
If you have additional questions or concerns regarding audit preparation, the audit appeal process, or safe billing and filling strategies, the PAAS team is here to guide you. Give us a call (608) 873-1342, email firstname.lastname@example.org or submit a question online through the PAAS Member Portal.
- FDA Issues Updates to iPLEDGE® REMS Program - February 7, 2024
- Law Enforcement Access to Protected Health Information – What’s Your Policy? - February 5, 2024
- News Article with Protected Health Information Led to an $80,000 HIPAA Settlement - January 4, 2024